Jennifer Tjia, MD, MSCE is an Associate Professor in the Department of
Medicine's Division of Geriatric Medicine at the University of Massachusetts Medical
School, with a secondary appointment in the Clinical and Population Health Research
Program, and a board-certified geriatrician. She is also a faculty member at the Meyers
Primary Care Institute. Dr. Tjia's research focuses on medication use and drug
safety in the elderly, specifically focusing on patient-centered prescribing and quality
of life outcomes in advanced illness. Older adults use a disproportionate number of
prescription medications and are at increased risk of drug-related injury. Recognizing
that the burden of unnecessary medication use in this population has not been well
studied, the goal of Dr. Tjia's research is to understand the effect of unnecessary
medication use on quality of life, and to develop a patient-centered intervention to
identify and manage these medications. 

Articles

Link

Studies to reduce unnecessary medication use in frail older adults: a systematic review (with Sarah J. Velten, Carole Parsons, Sruthi Valluri, and Becky A. Briesacher), Drugs and aging (2013)
 

Link

Antipsychotic use among nursing home residents (with Becky A. Briesacher, Terry S. Field, Daniel J. Peterson, and Jerry H. Gurwitz), JAMA : the journal of the American Medical Association (2013)
 

Link

Patient Completion of Laboratory Tests to Monitor Medication Therapy: A Mixed-Methods Study (with Shira H. Fischer, Terry S. Field, Shawn J. Gagne, Kathleen M. Mazor, Peggy Preusse, George W. Reed, Daniel J. Peterson, and Jerry H. Gurwitz), Journal of general internal medicine (2012)
 

Link

Dementia and risk of adverse warfarin-related events in the nursing home setting (with Terry S. Field, Kathleen M. Mazor, Jennifer L. Donovan, Abir O. Kanaan, George W. Reed, Peter Doherty, Leslie R. Harrold, and Jerry H. Gurwitz), The American journal of geriatric pharmacotherapy (2012)
 

Posters and Presentations

PDF

A Mixed-Methods Study To Characterize Pharmaceutical Marketing in the Nursing Home Setting: Off-Label Use of Atypical Antipsychotics (with Camilla Benedicto, Jennifer L. Donovan, Terry S. Field, Jerry H. Gurwitz, Sarah Foy, Leslie R. Harrold, Abir O. Kanaan, Celeste A. Lemay, Kathleen M. Mazor, Sruthi Valluri, and Becky A. Briesacher), Clinical and Translational Science Research Retreat (2012)
 

PDF

Do antipsychotic dose reduction trials result in worsening behavior among nursing home residents with dementia: a systematic review of the literature (with Abir O. Kanaan and Jennifer L. Donovan), Clinical and Translational Science Research Retreat (2012)
 

PDF

Factors Associated With Ordering Laboratory Monitoring Of High-Risk Medications (with Shira H. Fischer, Terry S. Field, Daniel J. Peterson, George Reed, and Jerry H. Gurwitz), Clinical and Translational Science Research Retreat (2012)
 

PDF

Knowledge of and perceived need for evidence-based educational materials about antipsychotic medication safety by nursing home staff (with Celeste A. Lemay, Sarah Foy, Kathleen M. Mazor, Leslie R. Harrold, Jennifer L. Donovan, Abir O. Kanaan, Becky A. Briesacher, and Jerry H. Gurwitz), Clinical and Translational Science Research Retreat (2012)
 

PDF

Patient Adherence to Laboratory Tests to Monitor Medication Therapy: A Mixed-Methods Study (with Shira H. Fischer, Terry S. Field, Shawn J. Gagne, Kathleen M. Mazor, Peggy Preusse, George Reed, Daniel J. Peterson, and Jerry H. Gurwitz), Clinical and Translational Science Research Retreat (2012)